The present invention relates to vaccine compositions comprising at least three variants of a subtype of an influenza A and/or B virus antigen, wherein the at least three variants are selected on the basis of differences between their amino acid sequences. The present invention further relates to said vaccine compositions for use in a method of generating an immune response against influenza viruses. Further provided is a method for producing said vaccine compositions.
|Publication status||Published - 26 Apr 2018|
Remarque, E. J. (2018). Influenza Virus Vaccine. (Patent No. WO2018073340). https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20180426&CC=WO&NR=2018073340A1&KC=A1